These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors. Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Kim M Diagn Microbiol Infect Dis; 2014 Jun; 79(2):273-9. PubMed ID: 24661685 [TBL] [Abstract][Full Text] [Related]
5. [The characteristics of Gram-positive bacteria isolated from skin lesions observed in ambulatory patients and the assessment of their susceptibility to antimicrobial drugs]. Sikora A; Kozioł-Montewka M; Bogut A Przegl Lek; 2011; 68(4):196-201. PubMed ID: 21853673 [TBL] [Abstract][Full Text] [Related]
6. [Linezolide--an antibiotic with new action mechanism]. Hedström SA Lakartidningen; 2002 Mar; 99(11):1201-2, 1205-8. PubMed ID: 11985017 [No Abstract] [Full Text] [Related]
7. [Therapy of skin and soft tissue infections from dermatologist's point of view]. Sunderkötter C Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S93-4. PubMed ID: 25429541 [No Abstract] [Full Text] [Related]
8. Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies. Montravers P; Bassetti M; Dupont H; Eckmann C; Heizmann WR; Guirao X; García MS; Capparella MR; Simoneau D; Bodmann KF J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii15-24. PubMed ID: 23772042 [TBL] [Abstract][Full Text] [Related]
9. Skin and soft tissue infection caused by Achromobacter xylosoxidans: report of 14 cases. Tena D; Martínez NM; Losa C; Solís S Scand J Infect Dis; 2014 Feb; 46(2):130-5. PubMed ID: 24325336 [TBL] [Abstract][Full Text] [Related]
10. [Daptomycin--a new antibiotic for the treatment of skin and soft tissue infections]. Mathiesen L; Midtvedt T; Solberg CO Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2383-4. PubMed ID: 16998552 [TBL] [Abstract][Full Text] [Related]
11. Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections. Morgan A; Cofer C; Stevens DL Future Microbiol; 2009 Mar; 4(2):131-44. PubMed ID: 19257839 [TBL] [Abstract][Full Text] [Related]
12. Alternative clinical indications for novel antibiotics licensed for skin and soft tissue infection? Dryden MS Curr Opin Infect Dis; 2015 Apr; 28(2):117-24. PubMed ID: 25692274 [TBL] [Abstract][Full Text] [Related]
13. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria. Stryjewski ME; O'Riordan WD; Lau WK; Pien FD; Dunbar LM; Vallee M; Fowler VG; Chu VH; Spencer E; Barriere SL; Kitt MM; Cabell CH; Corey GR; Clin Infect Dis; 2005 Jun; 40(11):1601-7. PubMed ID: 15889357 [TBL] [Abstract][Full Text] [Related]
15. Establishing the role of tigecycline in an era of antimicrobial resistance. Schafer JJ; Goff DA Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395 [TBL] [Abstract][Full Text] [Related]
16. Complicated infections of skin and skin structures: when the infection is more than skin deep. DiNubile MJ; Lipsky BA J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii37-50. PubMed ID: 15150182 [TBL] [Abstract][Full Text] [Related]
17. [Antibiotic therapy by suppurative diseases of the abdominal cavity and soft tissues]. Sazhin VP; Bodrova NG; Klimov DE; Iurishchev VA; Avdovenko AL; Sazhin IV Khirurgiia (Mosk); 2010; (6):4-9. PubMed ID: 20559216 [TBL] [Abstract][Full Text] [Related]